Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 5/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | APP | P05067 | 1/20 | 0.52 |
| ▸ | BCHE | P06276 | 1/20 | 0.50 |
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.50 |
| ▸ | AGXT | P21549 | 2/20 | 0.48 |
| ▸ | LTA4H | P09960 | 1/20 | 0.48 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5797808 | 0.98 | IDO1 (0.56) | IDO1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL6624910 | 0.84 | IDO1 (0.57) | IDO1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL28030165 | 0.83 | CASP3 (0.43) | IDO1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL7377840 | 0.82 | IDO1 (0.58) | IDO1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL62037 | 0.81 | IDO1 (0.59) | IDO1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL769511 | 0.81 | IDO1 (0.59) | IDO1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL1145768 | 0.79 | IDO1 (0.57) | IDO1ALDH1A1TP53CYP3A4ALOX15 | |
| Hydrochloric Acid SCHEMBL5797813 | 0.79 | IDO1 (0.60) | IDO1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL27586168 | 0.78 | NQO1 (0.58) | ALDH1A1TSHRSMN1; SMN2CA12CA1 | |
| SCHEMBL1145765 | 0.77 | ALDH1A1 (0.57) | IDO1ALDH1A1TP53CYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 186 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102558001-B | Manufacture the modification method of hydrazides | WYETH LLC (US) | 2015-09-23 | — | — | CN | claimed |
| US-20130224211-A1 | GLYCATED CD59 PEPTIDES, THEIR PREPARATION, AND USES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2013-08-29 | — | — | US | claimed |
| WO-2012027555-A2 | GLYCATED CD59 PEPTIDES, THEIR PREPARATION, AND USES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2012-03-01 | — | — | WO | claimed |
| US-12558656-B2 | Membranes and preparation thereof | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2026-02-24 | — | — | US | disclosed |
| US-11891448-B2 | Glycated CD59 peptides, their preparation, and uses thereof | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2024-02-06 | — | — | US | disclosed |
| US-20230140883-A1 | NOVEL MEMBRANES AND PREPARATION THEREOF | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2023-05-11 | — | — | US | disclosed |
| US-20220162333-A1 | GLYCATED CD59 PEPTIDES, THEIR PREPARATION, AND USES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2022-05-26 | — | — | US | disclosed |
| US-11324827-B2 | Multifunctionalized polyethylene glycol derivative and preparation method therefor | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2022-05-10 | — | — | US | disclosed |
| US-11161910-B2 | Glycated CD59 peptides, their preparation, and uses thereof | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2021-11-02 | — | — | US | disclosed |
| US-20180265589-A1 | GLYCATED CD59 PEPTIDES, THEIR PREPARATION, AND USES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2018-09-20 | — | — | US | disclosed |
| US-20170312363-A1 | MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2017-11-02 | — | — | US | disclosed |
| WO-1998019672-A9 | NITROSATED AND NITROSYLATED PHOSPHODIESTERASE INHIBITOR COMPOUNDS, COMPOSITIONS AND THEIR USES | — | 1998-09-11 | — | — | WO | disclosed |
| WO-1998019672-A1 | NITROSATED AND NITROSYLATED PHOSPHODIESTERASE INHIBITOR COMPOUNDS, COMPOSITIONS AND THEIR USES | NITROMED INC. (US) | 1998-05-14 | — | — | WO | disclosed |
| EP-0821589-A1 | COMPOSITIONS AND METHODS TO PREVENT TOXICITY INDUCED BY NONSTEROIDAL ANTIINFLAMMATORY DRUGS | Nitromed, Inc. (US) | 1998-02-04 | — | — | EP | disclosed |
| US-5703073-A | Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs | NITROMED, INC. (US) | 1997-12-30 | — | — | US | disclosed |
| WO-1997034871-A1 | NITROSATED AND NITROSYLATED COMPOUNDS AND COMPOSITIONS AND THEIR USE FOR TREATING RESPIRATORY DISORDERS | NITROMED, INC. (US) | 1997-09-25 | — | — | WO | disclosed |
| WO-1997027749-A1 | NITROSATED AND NITROSYLATED α-ADRENERGIC RECEPTOR ANTAGONIST COMPOUNDS, COMPOSITIONS AND THEIR USES | NITROMED, INC. (US) | 1997-08-07 | — | — | WO | disclosed |
| WO-1996032946-A1 | COMPOSITIONS AND METHODS TO PREVENT TOXICITY INDUCED BY NONSTEROIDAL ANTIINFLAMMATORY DRUGS | NITROMED, INC. (US) | 1996-10-24 | — | — | WO | disclosed |
| US-5196515-A | Thiolactone bifunctional chelating agents for diagnostic and therapeutic products | THE JOHNS HOPKINS UNIVERSITY (US) | 1993-03-23 | — | — | US | disclosed |
| US-5095111-A | Thiolactone bifunctional chelating agents for diagnostic and therapeutic products | THE JOHN HOPKINS UNIVERSITY (US) | 1992-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220162333-A1 | GLYCATED CD59 PEPTIDES, THEIR PREPARATION, AND USES THEREOF | CD59, SIGLEC9, CD209 | IDO1 2519/4885ALDH1A1 927/4885TP53 1193/4885 |
| US-11891448-B2 | Glycated CD59 peptides, their preparation, and uses thereof | CD59, SIGLEC9, CD209 | IDO1 2519/4885ALDH1A1 927/4885TP53 1193/4885 |
| US-20180265589-A1 | GLYCATED CD59 PEPTIDES, THEIR PREPARATION, AND USES THEREOF | CD59, SIGLEC9, CD209 | IDO1 2519/4885ALDH1A1 927/4885TP53 1193/4885 |
| US-11161910-B2 | Glycated CD59 peptides, their preparation, and uses thereof | CD59, SIGLEC9, CD209 | IDO1 2519/4885ALDH1A1 927/4885TP53 1193/4885 |
| US-12558656-B2 | Membranes and preparation thereof | EPCAM, B2M, AQP1 | IDO1 4703/4885ALDH1A1 3584/4885TP53 4236/4885 |
| US-11324827-B2 | Multifunctionalized polyethylene glycol derivative and preparation method therefor | HDGF, F11, F12 | IDO1 4313/4885ALDH1A1 1582/4885TP53 1477/4885 |
| US-20130224211-A1 | GLYCATED CD59 PEPTIDES, THEIR PREPARATION, AND USES THEREOF | CD59, SIGLEC9, CD209 | IDO1 2519/4885ALDH1A1 927/4885TP53 1193/4885 |
| US-20170312363-A1 | MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR | HDGF, F11, F12 | IDO1 4313/4885ALDH1A1 1582/4885TP53 1477/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.